Heterogeneous Contributing Factors in MPM Disease Development and Progression: Biological Advances and Clinical Implications

Malignant pleural mesothelioma (MPM) tumors are remarkably aggressive and most patients only survive for 5–12 months; irrespective of stage; after primary symptoms appear. Compounding matters is that MPM remains unresponsive to conventional standards of care; including radiation and chemotherapy. Cu...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Bhairavi Tolani, Luis A. Acevedo, Ngoc T. Hoang, Biao He
Format: Artigo
Langue:Inglês
Publié: MDPI AG 2018-01-01
Collection:International Journal of Molecular Sciences
Sujets:
malignant pleural mesothelioma (MPM)
tumor microenvironment heterogeneity
molecular pathways
tumor suppressors
immunotherapy
developmental cell pathways
Accès en ligne:http://www.mdpi.com/1422-0067/19/1/238
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires